Gyno-Pevaryl (Econazole Nitrate)

Gyno‑Pevaryl is indicated for the treatment of vulvovaginal candidiasis, a common yeast infection of the vagina and vulva.

• Local therapy of acute vulvovaginal candidiasis caused by Candida species.
• Adjunctive treatment for recurrent vulvovaginal yeast infections when prescribed by a healthcare professional.
• Management of mild to moderate fungal infections of the vaginal mucosa.
• Use in adult women for symptomatic relief of itching, burning, and discharge associated with candidal infection.
• Application as directed for prevention of infection recurrence after successful treatment.

The safety profile of Gyno‑Pevaryl reflects the typical adverse events reported with topical imidazole antifungals.

Common

• Mild vaginal irritation or burning sensation.
• Itching or mild pruritus at the application site.
• Transient vaginal discharge that may be watery or whitish.
• Local dryness or feeling of tightness.
• Mild discomfort during intercourse.

Serious

• Allergic contact dermatitis presenting as redness, swelling, or rash.
• Severe vaginal ulceration or ulcerative lesions.
• Persistent or worsening symptoms despite therapy.
• Signs of systemic hypersensitivity such as fever, hives, or swelling of the face.

Before using Gyno‑Pevaryl, certain precautions should be considered to ensure safe and effective treatment.

• Confirm diagnosis of vulvovaginal candidiasis before initiating therapy.
• Avoid use if you have a known hypersensitivity to econazole nitrate or other imidazole antifungals.
• Do not apply the product on inflamed, ulcerated, or damaged vaginal tissue without medical advice.
• Pregnancy and breastfeeding status should be discussed with a healthcare provider, as safety data are limited.
• If symptoms persist beyond the recommended treatment period, seek further medical evaluation.
• Do not use concomitantly with other intravaginal medications unless directed by a clinician.

Gyno‑Pevaryl may interact with other substances applied vaginally or systemic medications that affect fungal flora.

Avoid

• Concurrent use of other intravaginal antifungal agents without professional guidance.
• Application of vaginal spermicides or douches that could alter drug absorption.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase risk of adverse effects.
• Topical corticosteroids in the vagina, which could mask irritation.
• Hormonal contraceptives administered vaginally, though no direct interaction is established, monitor for efficacy.